Southern Symposium
Professor Michael Goggins
Professor of Pathology, Medicine and Oncology, Director of Pancreatic Cancer Early Detection Laboratory, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
Dr. Goggins is a Professor of Pathology, Medicine and Oncology at The Johns Hopkins
University School of Medicine. He was born in New York City and moved to the West
of Ireland as a teenager. He received his Bachelor’s degree and medical degree from
Trinity College Dublin in 1988 and completed his internship and internal medicine
training (1988-91) and gastroenterology and internal medicine fellowship training
(1991-5) in St. James Hospital, Dublin. He was a lecturer in Clinical Medicine at Trinity
from 1992-5. He then completed a research fellowship in Pathology and a clinical
fellowship in gastroenterology at Johns Hopkins University and joined the faculty in
1999. He was promoted to Professor of Pathology, Medicine and Oncology in 2008.
He has directed the Pancreatic Cancer Early Detection Research Laboratory since
1999. He is also an Attending Physician at Johns Hopkins Hospital in the Department
of Medicine, the Division of Gastroenterology/Hepatology and member of the Division
of Gastrointestinal Pathology and the Oncology Cancer.
Dr. Goggins has written or co-authored more than 250 peer-reviewed publications.
He was recognized a few years ago by Essential Science Indicators as the 6th-most
highly cited pancreatic cancer scientist over the previous decade. He is a member
of the Scientific Advisory Board of the Sol Goldman Pancreatic Cancer Research
Center at Johns Hopkins University. He has served on numerous national advisory
committees on pancreatic cancer. He has been a National Institute of Health grant
reviewer for over 10 years and serves on the NCI Cancer Oncology Trials and
Specialized Programs in Research Excellence (SPORE) study sections.
He is a member of the GISPORE, and the PACGENE and Panc4 consortia. The goals
of these studies include to identify new genes and markers of pancreatic cancer
susceptibility and diagnosis. As a member of the pancreatic cancer research team at
Johns Hopkins University, he was awarded the 2012 AACR Team Science award. He is
PI of a Research Acceleration Award from the Pancreatic Cancer Action Network to
fund a multicenter study (Cancer of the Pancreas Screening-5, CAPS5).
His early detection research focuses on evaluating the potential clinical utility of
measuring markers of early pancreatic cancer in pancreatic fluids and blood. The
ongoing CAPS5 study is measuring mutations in the pancreatic fluid of patients
undergoing pancreatic screening using next-generation sequencing.